CSWYY (China Shineway Pharmaceutical Group) Momentum Rank: 4 (As of Aug. 02, 2026) — 43% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CSWYY China Shineway Pharmaceutical Group Ltd CSWYY
88 GF Score
Price $19.25
GF Value $15.61
! 2 Warning Signs
View Full Analysis

What is China Shineway Pharmaceutical Group Momentum Rank?

China Shineway Pharmaceutical Group CSWYY 88 Momentum Rank is 4 as of Aug. 02, 2026, which is 43% below its 10-year median of 7.00. GuruFocus rates CSWYY with a GF Score™ of 88/100 and a GF Value™ of $15.61. The stock has 2 warning signs investors should review.

China Shineway Pharmaceutical Group has the Momentum Rank of 4.

Momentum Rank measures the strength and persistence of a stock's price movement over time, rated on a scale of 1 to 10.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

A higher score reflects strong price momentum and indicates greater potential for superior performance. Conversely, a lower score indicates that momentum is either too high or too low, and stocks tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

China Shineway Pharmaceutical Group Momentum Rank Related Terms

CSWYY vs ZTS: Momentum Rank Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Shineway Pharmaceutical Group Momentum Rank vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's Momentum Rank distribution charts can be found below:

* The bar in red indicates where China Shineway Pharmaceutical Group's Momentum Rank falls into.


CSWYY
88GF Score
China Shineway Pharmaceutical Group Ltd CSWYY
Momentum Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Momentum Rank →
What does a Momentum Rank of 4 mean?
China Shineway Pharmaceutical Group (CSWYY) has a Momentum Rank of 4 as of Aug. 02, 2026. Momentum Rank is determined using the standardized momentum ratio, measuring the speed and velocity of price changes in a stock. View historical data on China Shineway Pharmaceutical Group and its competitors. This is 43% below median its historical median of 7.00. Over the past decade, China Shineway Pharmaceutical Group's Momentum Rank has ranged from 1.00 to 10.00.
Is China Shineway Pharmaceutical Group's Momentum Rank too high?
China Shineway Pharmaceutical Group's current Momentum Rank of 4 is 43% below median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's Momentum Rank compare to ZTS?
China Shineway Pharmaceutical Group's Momentum Rank of 4 can be compared against companies in the Drug Manufacturers industry. Historically, China Shineway Pharmaceutical Group's own Momentum Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Momentum Rank for a Drug Manufacturers company?
A good Momentum Rank depends on the Drug Manufacturers industry context. However, Momentum Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Momentum Rank mean?
A high Momentum Rank can signal that a stock is expensive relative to its fundamentals. Momentum Rank is determined using the standardized momentum ratio, measuring the speed and velocity of price changes in a stock. View historical data on China Shineway Pharmaceutical Group and its competitors. China Shineway Pharmaceutical Group's current Momentum Rank is 4, which is 43% below median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYY) has a current Momentum Rank of 4. The stock's GF Value™ is $15.61, compared to a current price of $19.25 — trading 23.3% above its estimated fair value. The current Momentum Rank is 4, which is 43% below median its 10-year median of 7.00. China Shineway Pharmaceutical Group's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Momentum Rank calculated?
Momentum Rank is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYY), the current Momentum Rank is 4 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Shineway Pharmaceutical Group (CSWYY) Overvalued in 2026?

Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued. The current stock price of $19.25 is trading 23.3% above its estimated GF Value™ of $15.61.

Key valuation signals for CSWYY:

  • Momentum Rank: 4 (43% below median its 10-year median of 7.00)
  • GF Value™: $15.61 vs. price of $19.25 (23.3% above fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the CSWYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Shineway Pharmaceutical Group Business Description

Other Exchanges 02877:Hong KongC1S:Germany
Address Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
88GF Score

Get the complete analysis for CSWYY

Momentum Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.25
Price
$15.61
GF Value